Novel H3 receptor antagonists with improved pharmacokinetic profiles

A new series of H3 antagonists derived from the natural product Conessine are presented. Several compounds from these new series retain the potency and selectivity of earlier diamine based analogs while exhibiting improved PK characteristics. One compound (3u) demonstrated functional antagonism of the H3 receptor in an in vivo pharmacological model.

Figure optionsDownload as PowerPoint slide